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A criticism that has frequently been leveled against the
Spanish (and European) science system is the scarcity of
entrepreneurial initiatives that have originated in uni-
versities and research organizations in the country.
Several national and transnational initiatives are cur-
rently aimed at solving this deﬁciency and at bridging
the gap that prevents the commercial exploitation of
research-derived inventions. The results of these initia-
tives, however, have been far from satisfactory. Aca-
demic scientists trying to set up a new company to
market a discovery face a number of hurdles and mer-
maid songs that usually abort both momentum and
initiative.
The costs of establishing a new entrepreneurial soci-
ety are high. Academic life and aﬄuence are usually
strangers to each other. Hence, the participation of ex-
tra-academic partners is usually mandatory to establish
a production-based initiative. In Spain, national agen-
cies, such as the Center for Technological and Industrial
Development (CDTI), and an increasing number of re-
gional public and semi-public organizations aid in
establishing new technologically based companies. Par-
ticipation of these agencies ranges from oﬀering low-
interest rate loans to becoming involved as industrial
partners in the new companies for deﬁnite periods of
time. In addition, these agencies provide business advice
for academics. This help is oﬀered once the company (or
an initial version of it) has been established. The
administrative steps necessary to set up a company are
cumbersome, as is creating the necessary equilibrium
among the diﬀerent—private and public—partners in
the company. All these tasks are far removed from or-
dinary academic activities, and the success of scientists
taking on these responsibilities is usually far from opti-
mal.
The level of involvement of the founder scientist in
the new company also poses new problems. For a
company aimed at the production of material goods, the
investment in equipment and facilities is exceedingly
higher than the start-up capital. In accordance with the
Spanish Law of Contracts with Public Administrations,
if part of the developmental process is to be carried out
at public facilities, the participation of tenured aca-
demics in the society must be limited to 10%. This limits
dramatically the weight of the founder scientists in the
company and, consequently, the amount of the eco-
nomic return to them. Several universities have studied
diﬀerent initiatives to overcome this limitation, which
has discouraged the founder momentum, but a deﬁni-
tive, broadly accepted answer has not yet been found.
As an alternative to creating a new company, aca-
demic scientists can establish production-oriented re-
search contracts with already established companies.
This possibility allows scientists to escape from the
labyrinth described above, and increases the economic
return to them to the limits established by law. More-
over, because of the limits to the participation of aca-
demic scientists in commercial enterprises, the economic
return from direct contracts with an already established
company is higher than from a new company created
under the initiative of the scientist. However, the
drawback of such a model based on contracts between
scientists and established enterprises is twofold: (1) The
academic participates as a mere problem-solver for
the industry, not as a generator of new industries. (2)
The contracts for non-tenured scientists involved in this
scheme are of low quality—being essentially, similar to
fellowships.
Considering the three diﬀerent reasons for funding a
technologically based spin oﬀ, namely, economic return,
application of research results, and bridging the gap
between academia and industry, the costs of the ﬁrst
two, in terms of money, time and stamina, exceed the
beneﬁts. Therefore, cooperation with already established
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industries is a good alternative. Obviously, the preceding
considerations apply to industries aimed at developing
an actual product, not to the establishment of companies
that act as consultants.
Let us now consider whether the scarcity of good-
producing enterprises originating from academia is a
true problem or rather a pseudo-problem. Ideally, uni-
versities and research councils should produce knowl-
edge that can be commercially applied within a short
period of time. This statement is generally placed within
the framework of basic versus applied research. How-
ever, the framework for this discussion can be a diﬀerent
one. Universities are institutions where undergraduates
and Ph.D. candidates are trained for academic or pro-
fessional careers. Within the Spanish science system,
most research carried out at universities and at the
Spanish National Research Council (CSIC) relies on
students who are expected to develop original research
projects. Unfortunately, originality and commercial
application are, in many cases, contradictory. For in-
stance, in the ﬁeld of microbiology, antibiotic screening
is basic task for a Research and Development depart-
ment of a pharmaceutical company. It is, however, time-
consuming, has a low level of originality, and is
frequently a borderline subject for a Ph.D. or Master’s
thesis. Furthermore, for the daily operation of a pro-
ductive industry, professionals with diﬀerent academic
qualiﬁcations are needed. An industry whose manpower
is exclusively based on Ph.D.s or Ph.D. candidates can
produce very exciting academic discussions, but its per-
formance in the production of goods will probably be
far from acceptable. If academia concentrates on train-
ing scientist and on exploring new problems, it cannot
also concentrate on developing and marketing new
drugs.
In his classical speech to Dr. Martin Arrowsmith,
Prof. Gottlieb argues that the ‘‘action man’’ is a human
species completely diﬀerent from the real scientist. (In
his quest for pure science, the main character of the
novel Arrowsmith, by Sinclair Lewis, encounters mean-
ness, corruption, and misunderstanding.) Prof. Gottlieb
was almost a science version of a religious fundamen-
talist (as his name suggests), but he was quite right in
urging Martin Arrowsmith to decide whether he is going
to become a scientist or a producer, because the two
were hardly compatible. By contrast, Louis Pasteuris
hardly considered to have been an applied scientist, al-
though most of his work was aimed at solving applied
problems. While Pasteur tackled problems encountered
by diﬀerent industries, he was never an industrial
founder. Moreover, in his autobiography Salvador
E. Luriawrote that the university is aworld of scholarship
and trust, where the reward for success is intellectual
recognition, whereas industry is a world of contracts and
insecurity, where pay is the reward for work, and success
can make one expendable.
Perhaps a time is arriving (it is always arriving) in
which academia should clarify its objectives with respect
to it relationship to business, i.e., the generation and
transmission of knowledge, so-called know-how, and
abandon its attempts to reach unreachable stars that, in
addition, shine in parallel universes.
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